1Parsons MW, Bak A, Chalk J, et al. Diffusion-perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol, 2001, 51:28-36.
2Neuman-Haefelin T, Wittsack HT, Wenserski F, et al. Diffusion and perfusion-weighted MRI: the DWI/PWI mismatach region in acute stroke. Stroke,1999,30:1591-1597.
3Ross B, Kreis R. Clinical tools for the magnetic resonance spectroscopy and metabolite imaging. Eur Radiol,1992,14:128-131.
4Wardlaw JM, Marshall I, Wild J, et al. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurologic deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome.Stroke,199
5Yamamoto K, Roshimine T, Ranagihara T. Cerebral ischemia in rabbit: a new experimental model with immunohistochemical investigation. J Cereb Blood Flow Metab,1985, 5:529-536.
6Etroff OAC, Graham GD, Blamire AM, et al. Spectroscopic imaging of stroke in humans:histopathology correlates of spectral changes.Neurology,1992, 42:1349-1354.
7Barker PB, Gillaard JH, Vanzijl PCM, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging.Radiology,1994,192:723-732.
8Francesco F, Laura SI, Vincenzo L, et al. Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch Neurol,1998, 5:489-494.
9Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA,1995, 274:908-911.
10Fisher M. Characterizing the target of acute stroke therapy.Stroke,1997,28:866-872.
